CLPT
What one share of ClearPoint Neuro holds
Surgical and Medical Instruments and Apparatus
We are a commercial-stage medical device company, incorporated in 1998 as a Delaware corporation, that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain.
ClearPoint Neuro’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.45 |
|---|---|
| Profit | −$1.18 |
| Capex (buildings and equipment) | $0.04 |
| Free cash flow | −$1.07 |
| Cash and investments | $0.96 |
| Debt | $1.65 |
| Book value | $0.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $2.09 | −$2.93 | $0.04 | −$2.15 | — | −$0.21 |
| 2017 | $0.95 | −$0.93 | $0.00 | −$0.78 | — | $0.55 |
| 2018 | $0.67 | −$0.56 | $0.01 | −$0.43 | — | $0.14 |
| 2019 | $0.85 | −$0.42 | $0.00 | −$0.22 | — | $0.30 |
| 2020 | $0.81 | −$0.43 | $0.00 | −$0.50 | — | $0.14 |
| 2021 | $0.79 | −$0.69 | $0.01 | −$0.62 | — | $2.06 |
| 2022 | $0.85 | −$0.68 | $0.01 | −$0.68 | — | $1.50 |
| 2023 | $0.97 | −$0.90 | $0.03 | −$0.59 | — | $0.86 |
| 2024 | $1.16 | −$0.70 | $0.01 | −$0.34 | — | $0.92 |
| 2025 | $1.31 | −$0.90 | $0.02 | −$0.86 | — | $0.95 |